Objective: This study aims to develop a self-report questionnaire assessing the impact of vaginal dryness, soreness, itching, irritation, and pain on functioning and well-being in postmenopausal women.
To date, clinical studies of conditions that give rise to vaginal symptoms in postmenopausal women (such as vaginal atrophy) either have relied on physical or laboratory measures to assess severity and to evaluate treatment effects or have emphasized single-item ratings of change in women's Bmost bothersome symptom[ that do not adequately reflect the scope of impact of these symptoms on women's day-to-day lives. 1, 5, 6 At the 2007 New Interventions for Menopausal Symptoms conference, an expert panel expressed concern about the lack of validated measures for assessing vaginal symptoms across diverse populations of postmenopausal women and called for better methods for measuring improvement in quality of life with treatments for these symptoms. 7 To address this need, we developed the Day-to-Day Impact of Vaginal Aging (DIVA) questionnaire, a structured selfadministered questionnaire assessing the impact of vaginal symptoms such as dryness, irritation, itching, soreness, and pain on multiple dimensions of functioning and well-being, and we evaluated its preliminary psychometric properties in a multiethnic population of postmenopausal women. Our goal was to develop a sensitive and reliable instrument for administration in observational and therapeutic studies that has good face validity among clinicians and researchers and is relevant to symptomatic postmenopausal women across a range of ages and racial/ethnic backgrounds.
METHODS

Summary of measurement development process
Our methods for developing and examining the psychometric properties of the DIVA questionnaire included the following: (1) review of the literature and qualitative research to develop and refine our conceptual model; (2) development of a pool of structured self-report items and refinement based on one-onone cognitive pretesting interviews and assessment of face validity; (3) field testing of draft items in a community-based cohort to examine response variability and generalizability; (4) exploratory analyses to empirically identify the factor structure of the instrument, followed by confirmatory factor analysis to assess the fit of the empirically derived factor structure; (5) further exploration of construct validity by examination of hypothesized associations with measures of related constructs; and (6) evaluation of the internal consistency and test-retest reliability of our refined scales.
Development of a conceptual model through qualitative research
To develop a preliminary conceptual model of the impact of postmenopausal vaginal symptoms on women's functioning and well-being, we conducted focus groups with postmenopausal women aged 40 years or older who reported moderate to severe vaginal symptoms such as dryness, soreness, irritation, itching, or pain with sexual intercourse (dyspareunia). As described elsewhere, 44 symptomatic women, aged 48 to 75 years, from three racial/ethnic groups (black, Latina, and white) were recruited from the general San Francisco Bay area to participate in focus groups to discuss the impact of their vaginal symptoms on their activities, feelings, and relationships. 8 Focus groups consisted of 6 to 10 women and were led by trained moderators who were matched with participants for race/ethnicity, language, and general age. Findings were used to assess the relevance of potential functional and quality-of-life domains suggested by the existing literature to postmenopausal vaginal symptoms, identify additional domains affected by these symptoms, and assess variations in themes across age and racial/ethnic groups. Transcripts were independently analyzed by members of a multidisciplinary team using grounded theory, and the constant comparative method was used to resolve differences between team members. Because of this formative work, we identified five preliminary dimensions of functioning and well-being that had the potential to be affected by postmenopausal vaginal symptoms: (1) activities of daily living, (2) sexual functioning, (3) emotional well-being, (4) self-concept and body image, and (5) interpersonal relations. 8 Development of an item pool, assessment of face validity, and cognitive pretesting Based on the above concepts, we developed a preliminary pool of 100 structured self-report items to assess the impact of symptoms on the hypothesized domains. The items used fivepoint ordered response options to assess the degree to which vaginal symptoms interfered with specific aspects of women's day-to-day activities, sexual functioning, emotional well-being, self-concept and body image, or interpersonal relationships (eg, 0, not at all; 1, a little bit; 2, moderately; 3, quite a bit; 4, extremely). All of the items addressing impact on day-to-day activities, emotional well-being, self-concept and body image, and interpersonal relationships were designed to be applicable to all symptomatic women; however, a subset of items addressing impact on sexual function was appropriate only for sexually active women (ie, women with a history of vaginal sexual intercourse, other-partnered sexual activity, or unpartnered sexual activity such as self-stimulation or masturbation in the past 4 wk); these items included a Bnot applicable[ response option for women reporting no recent sexual activity.
For assessment of face validity among clinicians, a sample of 10 clinicians experienced in evaluating and treating women's health conditions (including gynecologists and general internists) was asked to review and rank preliminary items for their perceived relevance to postmenopausal women's lives. Items that received consistently poor rankings were eliminated for poor face validity.
We conducted one-on-one cognitive interview pretesting with 12 racially/ethnically diverse, symptomatic postmenopausal women to probe for the appropriateness and ambiguity of the remaining items. Participants were asked to comment on the clarity and appropriateness of the questionnaire instructions, item stems, and response options. Scripted and unscripted probes were used to explore the meaning of specific words or phrases, to assess whether similar items were perceived as redundant, to identify cognitive processes involved in answering questions, and to determine if any items were viewed as offensive. After every three interviews, problematic items were revised or eliminated, and the remaining items were reformatted for distribution to additional women. This resulting draft questionnaire consisted of 35 items; six of these items were applicable only to women with a history of sexual activity (either vaginal sexual intercourse or other types of sexual activity) in the prior 4 weeks.
Field testing in a community-based cohort
The draft questionnaire was administered in a multiethnic observational cohort study of community-dwelling middleaged and older women in northern CaliforniaVthe Reproductive Risks of Incontinence Study at Kaiser (RRISK). Details of the construction of the RRISK cohort have been reported elsewhere. 9 Briefly, participants were women aged 40 years or older who were long-time enrollees in the Kaiser Permanente Northern California integrated healthcare delivery system and were randomly sampled from within age and race/ethnicity strata to achieve an overall composition of approximately 20% Asian, 20% black, 20% Latina, and 40% white women. Although the goal of the parent RRISK was to identify risk factors for urinary tract dysfunction, no urinary tract symptoms were required for participation, and prior studies have indicated that RRISK participants are generally similar in clinical characteristics to female Kaiser Permanente Northern California enrollees at large. 9 During the third wave of RRISK visits conducted between November 2008 and April 2012, women who reported at least 6 months of spontaneous amenorrhea or who reported having undergone bilateral oophorectomy were asked if they had experienced symptoms such as vaginal dryness, soreness, itching, irritation, or pain with sexual intercourse in the past month. Those reporting at least one vaginal symptom were asked to complete the draft DIVA questionnaire and to provide further information about the bothersomeness of their symptoms. A subset of women drawn from all four racial/ethnic groups in the RRISK repeated self-administration of the questionnaire at home approximately 1 to 2 weeks after their study visits and returned it to study staff by mail. All participants provided an informed consent form before completing the draft questionnaire, and all data collection procedures were approved by the institutional review boards of the University of California San Francisco and the Kaiser Foundation Research Institute.
Item review and consolidation
After field testing, item response distributions were examined in the overall respondent sample and stratified by sexual activity status. Draft items that demonstrated poor response variability (eg, for which~85% to 90% of respondents reported minimal impact on the activity, feeling, or concept addressed by the question) or raised other concerns about generalizability or relevance to postmenopausal women in the general population were reexamined by the research team. Eight draft items were eliminated for poor response variability and/or concerns about conceptual relevance or generalizability, including items originally hypothesized to assess impact on activities of daily living (two items), emotional well-being (one item), self-concept and body image (one item), and interpersonal relations (four items). The preliminary interpersonal relations domain was subsequently eliminated because of insufficient number of items.
In addition, responses to two draft items addressing Bdesire or interest[ in (1) vaginal sexual intercourse and (2) other types of sexual activity, respectively, were replaced by a single combined response variable. The score for this combined item variable was assigned based on the type of sexual activity that was most affected by each woman's symptoms. Similarly, responses to two items examining frequency of (1) vaginal sexual intercourse and (2) other sexual activities, respectively, were replaced by a second combined response variable. Consolidation of the above items reduced the total number of questionnaire items to 25, of which four items were relevant only to women with a history of sexual activity in the prior 4 weeks (either vaginal sexual intercourse or other sexual activities).
Factor analysis models
Using the consolidated set of items, we fitted oblique principal components cluster analysis models (SAS PROC VARCLUS; SAS version 9.3; SAS Institute Inc, Cary, NC.) to provisionally identify a first-order factor questionnaire structure. 10 Solutions with 1 to 20 clusters were generated and evaluated to guide the selection of the solution that best balanced the parsimony and conceptual unidimensionality of item clusters. We fitted confirmatory factor analysis models via LISREL (version 9.10) 11 to evaluate the fit of the measurement models suggested by the chosen PROC VARCLUS cluster solutions. Goodness of confirmatory factor analysis model fit was assessed by examining the maximum likelihood and Satorra-Bentler scaled W 2 , 12 comparative fit index (CFI), 13 and standardized root-mean-square residual (SRMR). Consistent with past research, CFI values above 0.95 and SRMR values below 0.05 were considered to reflect approximate model fit. 14, 15 Because some DIVA questionnaire items were applicable only to women with a history of recent sexual activity, all factor analysis models were fitted twice: one set of models was fitted to the full respondent sample but used only the subset of 21 items that were relevant to all women regardless of sexual activity status; another set was fitted to the subset of women who reported being sexually active in the prior 4 weeks but used all 25 items. Although fewer than 1% of all DIVA questionnaire item responses were missing, we accommodated missing values via various methods: (i) for PROC VARCLUS, we used the expectation-maximization item covariance matrix; (ii) for confirmatory factor analysis model parameter and standard error estimates, and maximum likelihood W 2 , we used full information maximum likelihood; and (iii) for estimation of CFI and SRMR values, we used multiple imputation.
Evaluation of multi-item scale distributions and item-scale correlations
After confirmatory factor analysis, we created domain scale scores representing each first-order factor as the mean of corresponding item responses for each participant. We examined the distribution of multi-item scale scores and calculated item-scale and interscale correlations for these domain scales using r. For the sexual functioning scale, two separate scale versions were examined: a short version appropriate for all women regardless of sexual activity status and a longer version appropriate only for sexually active women.
Additional assessment of construct validity
To further evaluate the construct validity of the refined DIVA questionnaire scales, we examined correlations between these scales and three other self-report measures administered in the parent cohort. For these analyses, Pearson's r values indicate correlations between the DIVA questionnaire domain scales and these validity measures (G0. 20 16 and administered in other women's health outcome studies. 17, 18 Designed for women with a history of recent sexual activity, this measure assesses difficulty with sexual arousal, lubrication, orgasm, and pain in the past 3 months. Total scores, calculated by averaging the scores of individual items, range from 0 to 4; higher scores indicate more sexual activityYspecific problems. We hypothesized that women reporting greater impact of their vaginal symptoms on sexual functioning, as measured by the DIVA questionnaire sexual functioning scale, would also report worse overall sexual function, as measured by this generic sexual problems measure. We also anticipated that scores on the DIVA questionnaire self-concept and body image scale would be weakly correlated with scores on this generic sexual problems measure. (c) Hospital Anxiety and Depression Scale (HADS): HADS is an established 14-item instrument that assesses respondents' feelings of anxiety and depression in the past 4 weeks. 19 It consists of a seven-item subscale assessing depression and a seven-item subscale assessing cognitive anxiety. Subscale scores range from 0 to 21, with higher scores indicating greater depression or anxiety. 19 We hypothesized that women reporting greater impact of vaginal symptoms on their emotional well-being, as measured by the DIVA questionnaire, would also report greater depression and anxiety on both of these HADS subscales (Appendix B). Given that poor self-concept and body image can contribute to feelings of depression and anxiety, 20 we also hypothesized that scores on the DIVA questionnaire self-concept and body image scale would be weakly correlated with scores on the HADS anxiety and depression subscales.
Examination of reliability
Internal consistency reliability of the refined DIVA questionnaire domain scales was assessed using standardized Cronbach > values (e0.60, poor reliability; 0.61-0.70, moderate reliability; 0.71-0.80, good reliability; 90.80 excellent reliability). Test-retest reliability was assessed with intraclass correlation coefficients using data from a subset of 175 women drawn from all racial/ethnic groups who repeated administration of a mail-in version of the DIVA questionnaire 1 to 2 weeks after their initial visit (e0.40, poor correlation; 0.41-0.60, moderate correlation; 0.61-0.80, good correlation; Q0.80 excellent correlation).
RESULTS
Study population
Of the 757 symptomatic postmenopausal women in the parent RRISK3 cohort, 745 (98.4%) field-tested the draft DIVA questionnaire. The mean (SD) age of respondents was 56.2 (8.5) years (range, 41-81 y; Table 1 ). More than two thirds of the respondents were racial/ethnic minorities, including 20.5% Asian, 20.8% black, and 25.1% Latina women. More than three quarters of the respondents were married or reported being in a significant relationship. More than 40% of the participants described their overall health as being [5.9] , respectively, out of a total possible range of 0 to 50). Fewer than 30% of respondents overall were normal weight or underweight, with the majority being overweight or obese. The most commonly reported vaginal symptom among all respondents was dryness (76.4%), followed by itching (42.6%), pain with sexual intercourse (29.5%), irritation (28.7%), and soreness (14.2%; Table 2 ).
Factor analysis results
Based on PROC VARCLUS analyses, we ultimately selected four-factor solutions that corresponded to four of the original hypothesized domains, for both the full respondent sample and the sexually active subsample: (1) activities of daily living, (2) sexual functioning, (3) emotional well-being, and (4) self-concept and body image. During preliminary confirmatory factor analysis, we found that overall model fit was adequate both for the shorter version of the instrument completed by all women regardless of sexual activity status and for the longer version of the instrument completed by sexually active women only (CFI, 0.978 and 0.975; SRMR, 0.038 and 0.045, respectively). However, two items hypothesized to represent the emotional well-being domain each had low-value cross-loadings on two factors; these items were subsequently dropped and the models were refitted. For the refined models, including 19 items for the full sample and 23 items for the subsample of sexually active women (Table 3) Medications were assessed by abstraction of the pharmacy database records of women who reported filling at least 80% of medications at a Kaiser Permanente pharmacy and by self-report questionnaires for all other women. For this question, respondents could indicate that the question was not applicable to them because they had not had sexual intercourse recently; however, the prevalence of this symptom was calculated as a percentage of all respondents regardless of history of sexual intercourse. This five-item measure assesses the subjective bother associated with symptoms such as vaginal dryness, itching, irritation, soreness, and pain during sexual intercourse in the past month. Total scores range from 0 to 5, with higher scores indicating greater symptom bother. If a respondent indicated that she was not eligible to answer the question about pain during sexual intercourse (because of lack of recent sexual intercourse), the total score was calculated based on the remaining questions.
e This four-item measure assesses difficulty with sexual arousal, lubrication, orgasm, and pain during sexual activity and was administered only to women reporting sexual activity in the past 3 months. Total scores range from 0 to 4, with higher scores indicating more sexual activityYspecific problems.
f This 14-item measure consists of a 7-item subscale assessing depression and a 7-item subscale assessing cognitive anxiety in the past week. Subscale scores range from 0 to 21, with higher scores indicating greater depression or anxiety.
Scale distributions, correlations, and reliability
The final DIVA questionnaire consisted of four multi-item domain scales addressing the impact of women's vaginal symptoms on activities of daily living (five items), emotional well-being (four items), sexual functioning (five items for the short version and nine items for the longer version), and self-concept and body image (five items; Appendix A). Mean scores on each of the domain scales (which were calculated by averaging the scores of individual contributing items and were scaled so that higher scores indicated greater symptom impact) tended to be low, ranging from 0.29 to 0.85 in the possible range of 0 to 4 (Table 4), suggesting relatively low overall impact on this population-based sample of women. Item-scale correlations corrected for overlap were well above the 0.30 minimal threshold for all scales. Interscale r values ranged from 0.14 to 0.58. Internal consistency Cronbach > values ranged from 0.82 to 0.93. Test-retest correlations ranged from 0.47 to 0.72.
Additional examination of construct validity
Consistent with our hypotheses, we detected moderate to strong correlations between participants' scores on each of the DIVA questionnaire domain scales and their ratings of the overall bothersomeness of their vaginal symptoms (Table 5) . Also as hypothesized, scores on the DIVA questionnaire sexual functioning scale were strongly correlated with scores on the more generic Female Sexual Problems Measure. We also observed moderate correlations between scores on the DIVA questionnaire self-concept and body image scale and scores on this generic sexual problems measure. As hypothesized, there were also moderate correlations between DIVA questionnaire emotional well-being scale scores and HADS depression and anxiety subscales scores. We also observed weak to minimal correlations between the DIVA questionnaire selfconcept and body image scale and the HADS depression and anxiety subscales (Table 5) .
DISCUSSION
The DIVA questionnaire was developed to assess the impact of vaginal symptoms such as dryness, soreness, itching, irritation, and pain on functioning and well-being in postmenopausal women of diverse backgrounds. In addition to advancing overall scientific understanding of the impact of Test-retest intraclass coefficients were obtained from repeated administration of measures after 1 to 2 weeks in a subset of 175 women drawn from all racial/ethnic groups represented in the parent cohort. Correlations were assessed only in 462 women who reported sexual activity in the past 4 weeks because some measures used to assess construct validity were relevant only to sexually active women (ie, the Female Sexual Problems Measure). these vaginal symptoms, our goal was to promote a more effective evaluation of new treatments of postmenopausal vaginal symptoms by providing an instrument that could potentially be used to assess treatment-related changes in women's lived experience of these symptoms. Our measure development process, which included qualitative research in racially/ethnically diverse women, one-on-one cognitive interview pretesting of preliminary items, assessment of face validity, exploratory factor analysis, and confirmatory factor analysis, resulted in the creation of four multi-item scales addressing major domains of functioning and well-being. These scales were found to have excellent internal consistency reliability among the symptomatic postmenopausal women who completed the DIVA questionnaire. Correlation between scores at baseline and scores at repeated administration of the DIVA questionnaire was good for the emotional well-being and self-concept and body image scales, and moderate for the activities of daily living and sexual functioning scales.
Although our analyses provide preliminary evidence of construct validity, the factor analysis models reported here were exploratory in nature, and confirmatory testing of this fourfactor model in other respondent samples is needed. Moreover, further assessment of correlations between the DIVA questionnaire domain scales and other measures assessing similar constructs would be helpful in confirming that the DIVA questionnaire scales appropriately address the concepts they were designed to measure.
Research on the impact of postmenopausal vaginal symptoms is scarce and only a few other questionnaires addressing related or overlapping symptoms or conditions have previously been developed. The Urogenital Atrophy Quality of Life Questionnaire, a 20-item measure developed and tested in a sample of 96 postmenopausal women in the United Kingdom and Sweden, 23 includes items addressing vaginal soreness and itching; however, this measure also addresses urinary tract symptoms, such as incontinence and urgency, that are not necessarily associated with menopause. 24, 25 The Vulvovaginal Symptoms Questionnaire, a 21-item measure adapted from an existing measure of the impact of skin disease symptoms, was developed in a sample of 120 primarily white postmenopausal women presenting to a gynecology practice. 26 Because most items in this questionnaire assess the presence or impact of vulvar symptoms (ie, vulvar itching, burning, hurting, irritation, and dryness), this instrument may be more appropriate for women who have primarily vulvar symptoms rather than vaginal symptoms.
Even though women who completed the DIVA questionnaire as part of the parent cohort study provided information on a wide variety of demographic and clinical variables, they did not undergo pelvic examination or laboratory testing to evaluate the etiology of their symptoms. In addition to vaginal atrophy, other potential causes of vaginal symptoms in postmenopausal women include vaginal infections, contact allergy or irritation, and malignant or premalignant lesions. Future research should assess for differences in the psychometric properties of the DIVA questionnaire among postmenopausal women with physical or laboratory signs of vaginal atrophy as opposed to other clinicopathologic processes. In addition, the cross-sectional design of the parent RRISK did not allow us to assess whether women experienced vaginal symptoms earlier in life, such as before the cessation of menses. The severity, quality, and impact of women's vaginal symptoms may differ depending on the amount of time since symptom onset or the context in which they first developed. Vaginal symptoms developing before the cessation of menses are less likely to be caused directly or exclusively by hormonal changes associated with menopause.
Several other limitations of this research should be noted. Although our analyses were conducted in a racially/ethnically diverse sample of women, all participants were from Northern California and were long-time enrollees in Kaiser Permanente. Future research should evaluate the generalizability of these findings by assessing the properties of this instrument in women of more diverse backgrounds. In addition, overall symptom burden in our study sample was low, given that RRISK3 was a community-based cohort study that was not specifically designed to assess vaginal symptoms. The psychometric properties of the DIVA questionnaire may differ in clinical or referral populations, such as women presenting specifically for treatment of vaginal symptoms. Furthermore, as already noted, our empirical DIVA questionnaire measurement model was based on exploratory analyses. Therefore, findings should be considered provisional and require confirmation in subsequent samples.
CONCLUSIONS
The DIVA questionnaire is a new, structured, self-administered measure of the impact of postmenopausal vaginal symptoms on women's activities of daily living, emotional well-being, sexual functioning, and self-concept and body image. When used in conjunction with a screening measure of the presence and bothersomeness of vaginal symptoms, this questionnaire may be helpful in facilitating the evaluation of the impact of vaginal symptoms on postmenopausal women across a range of ages and backgrounds.
